-+ 0.00%
-+ 0.00%
-+ 0.00%

Ultragenyx Stock Sinks 47% on Drug Trial Failure. Why Wall Street Isn't Giving Up Yet.

Barron‘s·09/03/2026 11:46:00

登錄查看新聞詳情